$2.62
-0.17-5.92%
At close: -
$2.90
0.2810.69%
After Hours: Apr 17, 4:00 AM EDT
Comments
Loading...
Latest Rain Enhancement Stock News | NASDAQ:RAIN | Benzinga
Get the latest news on Rain Enhancement stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Rain Enhancement performance
Categories: All
Tuesday, February 11, 2025
Wednesday, January 29, 2025
Monday, January 06, 2025
Friday, January 19, 2024
Thursday, December 14, 2023
Thursday, November 09, 2023
Monday, October 16, 2023
Friday, October 13, 2023
Tuesday, October 03, 2023
Monday, September 18, 2023
Monday, September 11, 2023
Thursday, September 07, 2023
Monday, August 28, 2023
Thursday, August 10, 2023
Monday, July 24, 2023
Friday, June 16, 2023
Monday, June 05, 2023
Friday, June 02, 2023
- Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Rain Oncology 10% Owner Makes $1.16M Stock Purchase
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
- Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
- HC Wainwright & Co. Reiterates Neutral on Rai...
Thursday, June 01, 2023
Tuesday, May 30, 2023
- Stocks That Hit 52-Week Lows On Tuesday
- Roth MKM Downgrades Rain Oncology to Neutral,...
- EF Hutton Maintains Hold on Rain Oncology, Lo...
- Rain Oncology Provides Company Update And Outlines Strategic Priorities Of Milademetan Clinical Programs; Workforce Reduction Of ~65% Of The Company's Employees; With A Transition Of Chief Medical Officer Responsibilities
Thursday, May 25, 2023
Tuesday, May 23, 2023
- Analyst Expectations for Rain Oncology's Future
- Rain Oncology's Phase 3 Data Casts Doubt On Other Trials: Analyst Reevaluate Their Views
- Benzinga's Top Ratings Upgrades, Downgrades For May 23, 2023
- Citigroup Downgrades Rain Oncology to Neutral...
- JonesTrading Downgrades Rain Oncology to Hold
- HC Wainwright & Co. Downgrades Rain Oncology ...
- Piper Sandler Downgrades Rain Oncology to Neu...
- Oppenheimer Downgrades Rain Oncology to Perfo...
- EF Hutton Downgrades Rain Oncology to Hold, L...
Monday, May 22, 2023
- Rain Oncology Shares Plummet: Company Discloses Disappointing Cancer Study Data After Delaying Readout
- Dow Tumbles 100 Points; Micron Technology Shares Plunge
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Stocks That Hit 52-Week Lows On Monday
- Nasdaq Rises Over 50 Points; Greenhill Shares Spike Higher
